← The Wire
TOVXNYSE
Theriva Biologics, Inc.
Pharmaceutical Preparations · NV · CIK 894158
Developing oncolytic adenovirus therapeutics to treat cancer and related diseases
$14M
Market cap
$0.26
Last close
+4.1%
1D
+2.8%
5D
1.2M
Volume
Price · last 39 sessions-31.5%
May 4L $0.24 · H $0.38Jun 29
572
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
DEF 14ADEF 14AJun 29, 2026DEF 14ADEF 14AApr 30, 2026DEF 14ADEF 14AMar 16, 2026DEF 14ADEF 14AJan 5, 2026DEF 14ADEF 14ANov 10, 2025DEF 14AFORM DEF 14AJul 9, 2025DEF 14ADEF 14ASep 30, 2024DEF 14ADEF 14AAug 14, 2023DEF 14ADEF 14AAug 16, 2022DEF 14ADEF 14AAug 16, 2021DEF 14ADEF 14AAug 4, 2020DEF 14ADEF 14AJul 15, 2019DEF 14ADEFINITIVE PROXY STATEMENTAug 14, 2018DEF 14ADEF 14AJul 18, 2017DEF 14ADEF 14AJul 6, 2016DEF 14ADEF 14AApr 13, 2015DEF 14ADEF 14AMay 12, 2014DEF 14ADEF 14ASep 24, 2013DEF 14ASCHEDULE 14ASep 11, 2012DEF 14ADEFINITIVE PROXY STATEMENTJan 4, 2012DEF 14ADEF 14AJun 20, 2011DEF 14ADEF 14ASep 29, 2010DEF 14ADEFINITIVE 14ANov 20, 2009DEF 14ADEF 14AApr 29, 2008DEF 14ADEF 14AOct 9, 2007DEF 14ADEFINITIVE PROXY STATEMENTApr 30, 2002DEF 14ADEFINITIVE PROXY STATEMENTApr 6, 2001DEF 14ADEFINITIVE PROXY STATEMENTApr 5, 2000DEF 14ADEFINITIVE PROXY STATEMENTDec 13, 1999DEF 14APRELIMINARY PROXY STATEMENTMay 28, 1999DEF 14ADEFINITIVE PROXYJun 23, 1998
Similar companies
Comparable business profile · signals at a glance